Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-041424
Filing Date
2021-06-17
Accepted
2021-06-17 16:15:46
Documents
1
Period of Report
2021-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3935
  Complete submission text file 0001209191-21-041424.txt   5291
Mailing Address 7255 WOODMONT AVE BETHESDA MD 20814
Business Address
COHEN ALAIN J (Reporting) CIK: 0001132946 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39567 | Film No.: 211024928

Mailing Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 200 WATERTOWN MA 02472 (617) 231-0700
C4 Therapeutics, Inc. (Issuer) CIK: 0001662579 (see all company filings)

EIN.: 475617627 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)